{"id":13948,"date":"2025-01-02T09:39:58","date_gmt":"2025-01-02T17:39:58","guid":{"rendered":"https:\/\/depts.washington.edu\/diabetes\/?p=13948"},"modified":"2025-01-02T09:39:58","modified_gmt":"2025-01-02T17:39:58","slug":"mifepristone-shows-promise-for-diabetes-with-hypercortisolism","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/diabetes\/mifepristone-shows-promise-for-diabetes-with-hypercortisolism\/","title":{"rendered":"Mifepristone shows promise for diabetes with hypercortisolism"},"content":{"rendered":"<section class=\"kc-elm kc-css-658541 kc_row\"><div class=\"kc-row-container  kc-container\"><div class=\"kc-wrap-columns\"><div class=\"kc-elm kc-css-440879 kc_col-sm-12 kc_column kc_col-sm-12\"><div class=\"kc-col-container\"><div class=\"kc-elm kc-css-353413 kc_text_block\"><p>Mifepristone significantly reduced A1C in patients with hypercortisolism and difficult-to-control type 2 diabetes, according to results from the CATALYST study presented at the World Congress on Insulin Resistance, Diabetes &amp; Cardiovascular Disease. The group taking mifepristone had a mean A1C reduction of 1.47% at 24 weeks compared with 0.15% for the group receiving a placebo.<\/p>\n<p>\u00a0Full Story: <a href=\"https:\/\/www.healio.com\/news\/endocrinology\/20241230\/mifepristone-reduces-hba1c-in-patients-with-hypercortisolism-type-2-diabetes\">Healio (free registration)<\/a> (12\/30)\u00a0\u00a0<\/p>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<\/div><\/div><\/div><\/div><\/div><\/section><!-- \/wp:post-content -->","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false,"footnotes":""},"categories":[17],"tags":[],"class_list":["post-13948","post","type-post","status-publish","format-standard","hentry","category-diabetes-related-news"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13948","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/comments?post=13948"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13948\/revisions"}],"predecessor-version":[{"id":13949,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13948\/revisions\/13949"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/media?parent=13948"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/categories?post=13948"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/tags?post=13948"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}